Designed Helical Peptides as Functional Probes for γ-Secretase
Biochemistry
|October 19, 2019
Summary
Researchers developed synthetic substrates to study gamma-secretase activity in Alzheimer's disease (AD). These probes mimic amyloid precursor protein (APP) processing, revealing how familial AD mutations alter amyloid-beta peptide production.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Gamma-secretase is a protease complex crucial for processing amyloid precursor protein (APP).
- APP processing by gamma-secretase produces amyloid-beta (Aβ) peptides, including Aβ42, which aggregates in Alzheimer's disease (AD).
- Familial AD is linked to mutations in APP and presenilin, affecting gamma-secretase activity.
Purpose of the Study:
- To develop synthetic APP transmembrane domain (TMD) substrates as functional probes for gamma-secretase.
- To investigate how familial AD mutations alter APP processing by gamma-secretase.
- To elucidate the pathogenic mechanisms of AD and inform therapeutic strategies.
Main Methods:
- Designed synthetic APP-based TMD substrates incorporating helix-inducing residues for improved synthesis and solubility.
- Utilized mass spectrometry to analyze proteolytic products generated by gamma-secretase.
- Introduced familial AD mutations into synthetic substrates to assess their impact on Aβ production pathways.
Main Results:
- Synthetic substrates accurately reproduced physiological APP processing by gamma-secretase.
- Mutated substrates showed altered processing, leading to increased production of longer Aβ-like peptides (e.g., Aβ45 and longer).
- This suggests a potential role for longer Aβ peptides in AD pathogenesis.
Conclusions:
- Synthetic APP-TMD substrates are effective tools for studying gamma-secretase activity and substrate processing.
- Familial AD mutations may increase the production of longer Aβ peptides, contributing to disease pathology.
- Further research is needed to confirm the role of these longer Aβ peptides in AD pathogenesis.


